Skip to main content

previous disabled Page of 2
and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm

Include preview-only content
  1. Article

    Open Access

    Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

    Zhi-Guo Zhou, Di-Xuan Jiang, Shu-Min **e in Signal Transduction and Targeted Therapy (2020)

  2. Article

    Open Access

    CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

    In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no specific and effective drugs for treating this disease have been reported until today. Angiotensin-converting enzyme ...

    Ke Wang, Wei Chen, Zheng Zhang, Yongqiang Deng in Signal Transduction and Targeted Therapy (2020)

  3. Article

    Open Access

    Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

    Derived from our original nomogram study by using the risk variables from multivariable analyses in the derivation cohort of 1383 patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL) who were mostl...

    Si-Ye Chen, Yong Yang, Shu-Nan Qi, Ying Wang, Chen Hu, **a He, Li-Ling Zhang in Leukemia (2021)

  4. Article

    Open Access

    UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development

    Genomic sequencing analysis of tumors provides potential molecular therapeutic targets for precision medicine. However, identifying a key driver gene or mutation that can be used for hepatocellular carcinoma (...

    Ren-Yu Zhang, Ze-Kun Liu, Ding Wei, Yu-Le Yong in Signal Transduction and Targeted Therapy (2021)

  5. Article

    Open Access

    Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome

    Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne virus with high fatality and an expanding endemic. Currently, effective anti-SFTSV intervention remains unavailable. F...

    Hao Li, **a-Ming Jiang, Ning Cui, Chun Yuan in Signal Transduction and Targeted Therapy (2021)

  6. Article

    Open Access

    Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

    Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SAR...

    Huijie Bian, Zhao-Hui Zheng, Ding Wei in Signal Transduction and Targeted Therapy (2021)

  7. Article

    Open Access

    Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant

    Safety and efficacy of allogeneic anti-CD19 chimeric antigen receptor T cells (CAR-T cells) in persons with CD19-positive B-cell acute lymphoblastic leukemia (B-ALL) relapsing after an allotransplant remain un...

    Cheng Zhang, **ao-Qi Wang, Rong-Li Zhang, Fang Liu, Yi Wang, Zhi-Ling Yan in Leukemia (2021)

  8. Article

    Open Access

    Fructose drives mitochondrial metabolic reprogramming in podocytes via Hmgcs2-stimulated fatty acid degradation

    Lei Fang, Tu-Shuai Li, **g-Zi Zhang in Signal Transduction and Targeted Therapy (2021)

  9. Article

    Open Access

    CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression

    Major gaps in understanding the molecular mechanisms of colorectal cancer (CRC) progression and intestinal mucosal repair have hampered therapeutic development for gastrointestinal disorders. Trefoil factor 3 ...

    Hong-Yong Cui, Shi-Jie Wang, Fei Song, Xu Cheng in Signal Transduction and Targeted Therapy (2021)

  10. Article

    Open Access

    RHBDF1 promotes AP-1-activated endothelial–mesenchymal transition in tumor fibrotic stroma formation

    Shan Gao, Li-Song Zhang, Lei Wang, Nan-Nan **ao in Signal Transduction and Targeted Therapy (2021)

  11. Article

    Open Access

    CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma

    SARS-CoV-2 mutations contribute to increased viral transmissibility and immune escape, compromising the effectiveness of existing vaccines and neutralizing antibodies. An in-depth investigation on COVID-19 pat...

    Jiejie Geng, Liang Chen, Yufeng Yuan, Ke Wang in Signal Transduction and Targeted Therapy (2021)

  12. Article

    Open Access

    Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis

    Met tyrosine kinase, a receptor for a hepatocyte growth factor (HGF), plays a critical role in tumor growth, metastasis, and drug resistance. Mitochondria are highly dynamic and undergo fission and fusion to m...

    Yan Yu, **ao-Dan Peng, **ao-Jun Qian in Signal Transduction and Targeted Therapy (2021)

  13. Article

    Open Access

    Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence

    Patients with hepatocellular carcinoma (HCC) have poor long-term survival following curative resection because of the high rate of tumor early recurrence. Little is known about the trajectory of genomic evolut...

    Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song in Signal Transduction and Targeted Therapy (2022)

  14. Article

    Open Access

    BOD1 regulates the cerebellar IV/V lobe-fastigial nucleus circuit associated with motor coordination

    Cerebellar ataxias are characterized by a progressive decline in motor coordination, but the specific output circuits and underlying pathological mechanism remain poorly understood. Through cell-type-specific ...

    **u-**u Liu, **ng-Hui Chen, Zhi-Wei Zheng in Signal Transduction and Targeted Therapy (2022)

  15. Article

    Open Access

    CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis

    COVID‐19 patients can develop clinical and histopathological features associated with fibrosis, but the pathogenesis of fibrosis remains poorly understood. CD147 has been identified as a universal receptor for...

    Jiao Wu, Liang Chen, Chuan Qin, Fei Huo in Signal Transduction and Targeted Therapy (2022)

  16. Article

    Open Access

    Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial

    An ongoing randomized, double-blind, controlled phase 2 trial was conducted to evaluate the safety and immunogenicity of a mosaic-type recombinant vaccine candidate, named NVSI-06-09, as a booster dose in subj...

    Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu in Signal Transduction and Targeted Therapy (2023)

  17. Article

    Open Access

    Nucleic acid drug vectors for diagnosis and treatment of brain diseases

    Nucleic acid drugs have the advantages of rich target selection, simple in design, good and enduring effect. They have been demonstrated to have irreplaceable superiority in brain disease treatment, while vect...

    Zhi-Guo Lu, Jie Shen, Jun Yang, **g-Wen Wang in Signal Transduction and Targeted Therapy (2023)

  18. Article

    Open Access

    Immunological and metabolic characteristics of the Omicron variants infection

    The Omicron variants of SARS-CoV-2, primarily authenticated in November 2021 in South Africa, has initiated the 5th wave of global pandemics. Here, we systemically examined immunological and metabolic characte...

    Jiejie Geng, Xu Yang, Kun Wang, Ke Wang in Signal Transduction and Targeted Therapy (2023)

  19. Article

    Open Access

    Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

    Meplazumab, a humanized CD147 antibody, has shown favourable safety and efficacy in our previous clinical studies. In DEFLECT (NCT04586153), 167 patients with severe COVID-19 were enroled and randomized to rec...

    Huijie Bian, Liang Chen, Zhao-Hui Zheng in Signal Transduction and Targeted Therapy (2023)

  20. Article

    Open Access

    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC...

    Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 2